Cargando…

Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?

Owing to the global exponential increase in population ageing, there is an urgent unmet need to develop reliable strategies to slow down and delay the ageing process. Age-related neurodegenerative diseases are among the main causes of morbidity and mortality in our contemporary society and represent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Chul-Kyu, Sachdev, Perminder S, Braidy, Nady
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JKL International LLC 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782556/ https://www.ncbi.nlm.nih.gov/pubmed/35111369 http://dx.doi.org/10.14336/AD.2021.0705

Ejemplares similares

The Plasma NAD(+) Metabolome Is Dysregulated in “Normal” Aging
por: Clement, James, et al.
Publicado: (2019)

Differential expression of sirtuins in the aging rat brain
por: Braidy, Nady, et al.
Publicado: (2015)

Identification of Cerebral Metal Ion Imbalance in the Brain of Aging Octodon degus
por: Braidy, Nady, et al.
Publicado: (2017)

Corrigendum: Identification of Cerebral Metal Ion Imbalance in the Brain of Ageing Octodon degus
por: Braidy, Nady, et al.
Publicado: (2017)

Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy
por: Cardoso, Fabrízio dos Santos, et al.
Publicado: (2022)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Comparison of Single Phase and Biphasic Extraction Protocols for Lipidomic Studies Using Human Plasma
por: Wong, Matthew Wai Kin, et al.
Publicado: (2019)

Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics
por: Olson, David E
Publicado: (2018)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

Metal and complementary molecular bioimaging in Alzheimer's disease
por: Braidy, Nady, et al.
Publicado: (2014)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Updates and advances in multiple sclerosis neurotherapeutics
por: Amin, Moein, et al.
Publicado: (2022)

Plasma lipidome variation during the second half of the human lifespan is associated with age and sex but minimally with BMI
por: Wong, Matthew Wai Kin, et al.
Publicado: (2019)

The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ(40) Oligomers in Human Astrocytes
por: Braidy, Nady, et al.
Publicado: (2019)

Evaluation of Dimercaptosuccinic Acid-Coated Iron Nanoparticles Immunotargeted to Amyloid Beta as MRI Contrast Agents for the Diagnosis of Alzheimer’s Disease
por: Ulanova, Marina, et al.
Publicado: (2023)

Neuroprotective, neurotherapeutic, and neurometabolic effects of carbon monoxide
por: Mahan, Vicki L
Publicado: (2012)

The social neuroscience of psychosis: From neurobiology to neurotherapeutics
por: Mehta, Urvakhsh Meherwan
Publicado: (2020)

Neuropsychiatry: Where Are We And Where Do We Go From Here?
por: Sachdev, Perminder S., et al.
Publicado: (2013)

Upregulation of Glycolytic Enzymes, Mitochondrial Dysfunction and Increased Cytotoxicity in Glial Cells Treated with Alzheimer’s Disease Plasma
por: Jayasena, Tharusha, et al.
Publicado: (2015)

Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
por: Liu, Yue, et al.
Publicado: (2021)

Molecular Mechanisms of Astaxanthin as a Potential Neurotherapeutic Agent
por: Bahbah, Eshak I., et al.
Publicado: (2021)

Biomaterials for Neurotherapeutics: From Lab Discovery to Clinical Application
por: Ao, Qiang
Publicado: (2021)

Neurosteroids as stress modulators and neurotherapeutics: lessons from the retina
por: Izumi, Yukitoshi, et al.
Publicado: (2022)

Neurotherapeutic potential of intranasal administration of human breast milk
por: Malhotra, Atul
Publicado: (2023)

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2023)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

A novel neurotherapeutic for multiple sclerosis, ischemic injury, methamphetamine addiction, and traumatic brain injury
por: Vandenbark, Arthur A., et al.
Publicado: (2019)

Aquatic training in MS: neurotherapeutic impact upon quality of life
por: Frohman, Ashley N, et al.
Publicado: (2015)

Neurotherapeutics for Attention Deficit/Hyperactivity Disorder (ADHD): A Review
por: Rubia, Katya, et al.
Publicado: (2021)

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Safety of general anaesthetics on the developing brain: are we there yet?
por: Robinson, Emily J., et al.
Publicado: (2022)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease
por: Braidy, Nady, et al.
Publicado: (2016)

Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects
por: Mouhieddine, Tarek H., et al.
Publicado: (2014)

Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system
por: Simon, Florian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9oteo0hoicerioptpsem9l8lbf